Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1296

1.

Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?

Heng AE, Cellarier E, Aublet-Cuvelier B, Decalf V, Motreff P, Marcaggi X, Deteix P, Souweine B.

Clin Nephrol. 2008 Dec;70(6):475-84.

PMID:
19049703
2.

Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.

Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM.

Nephrol Dial Transplant. 2008 Apr;23(4):1241-5. doi: 10.1093/ndt/gfm785. Epub 2008 Jan 3.

3.

Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.

Adolph E, Holdt-Lehmann B, Chatterjee T, Paschka S, Prott A, Schneider H, Koerber T, Ince H, Steiner M, Schuff-Werner P, Nienaber CA.

Coron Artery Dis. 2008 Sep;19(6):413-9. doi: 10.1097/MCA.0b013e3283021ac6.

PMID:
18955835
4.
5.

N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.

Staniloae CS, Doucet S, Sharma SK, Katholi RE, Mody KR, Coppola JT, Solomon R.

J Interv Cardiol. 2009 Jun;22(3):261-5. doi: 10.1111/j.1540-8183.2009.00456.x. Epub 2009 Mar 13.

PMID:
19490358
6.

Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.

Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A.

Circulation. 2007 Mar 13;115(10):1211-7. Epub 2007 Feb 19.

7.
8.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
9.

Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.

Boccalandro F, Amhad M, Smalling RW, Sdringola S.

Catheter Cardiovasc Interv. 2003 Mar;58(3):336-41.

PMID:
12594698
10.

Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.

Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, Gelormini JL, Labinaz M, Moreyra AE; Investigators of the CARE Study.

Circulation. 2007 Jun 26;115(25):3189-96. Epub 2007 Jun 11.

12.

[Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].

Hoshino A, Enomoto S, Kawahito H, Kurata H, Nakahara Y, Nakamura T.

J Cardiol. 2007 Aug;50(2):119-26. Japanese.

PMID:
17802695
13.

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.

Webb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, Al Shamari A, Sutander A, Williams T, Fox RS, Levin A.

Am Heart J. 2004 Sep;148(3):422-9.

PMID:
15389228
14.

Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.

Vasheghani-Farahani A, Sadigh G, Kassaian SE, Khatami SM, Fotouhi A, Razavi SA, Mansournia MA, Yamini-Sharif A, Amirzadegan A, Salarifar M, Sadeghian S, Davoodi G, Borumand MA, Esfehani FA, Darabian S.

Am J Kidney Dis. 2009 Oct;54(4):610-8. doi: 10.1053/j.ajkd.2009.05.016. Epub 2009 Jul 19.

PMID:
19619921
15.

Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.

Maioli M, Toso A, Leoncini M, Gallopin M, Tedeschi D, Micheletti C, Bellandi F.

J Am Coll Cardiol. 2008 Aug 19;52(8):599-604. doi: 10.1016/j.jacc.2008.05.026.

16.

Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.

Ochoa A, Pellizzon G, Addala S, Grines C, Isayenko Y, Boura J, Rempinski D, O'Neill W, Kahn J.

J Interv Cardiol. 2004 Jun;17(3):159-65.

PMID:
15209578
17.

Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.

CalabrĂ² P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, CalabrĂ² R.

Minerva Cardioangiol. 2010 Feb;58(1):35-40.

PMID:
20145594
18.

N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.

Baskurt M, Okcun B, Abaci O, Dogan GM, Kilickesmez K, Ozkan AA, Ersanli M, Gurmen T.

Eur J Clin Invest. 2009 Sep;39(9):793-9. doi: 10.1111/j.1365-2362.2009.02173.x. Epub 2009 Jun 5.

PMID:
19500141
19.

Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.

Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.

Eur Rev Med Pharmacol Sci. 2013 Feb;17 Suppl 1:13-21.

20.

Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.

El-Hajjar M, Bashir I, Khan M, Min J, Torosoff M, DeLago A.

Am J Cardiol. 2008 Aug 1;102(3):353-6. doi: 10.1016/j.amjcard.2008.03.067. Epub 2008 May 29.

PMID:
18638601
Items per page

Supplemental Content

Write to the Help Desk